Table 4.
Several editions of World Health Organization (pathological classification)
| Edition | Grading standards | |||
| 2000/2004 | G1: Well-differentiated NET; ≤ 2 cm in size, Ki-67 ≤ 2% | G2: Well-differentiated NEC; > 2 cm in size, Ki-67 3%-20% or angioinvasive | G3: Poorly differentiated NEC; Ki-67 > 20% | |
| 2010 | NET-G1: Well-differentiated, mitotic count < 2/2 mm2, Ki-67 ≤ 2% | NET-G2: Well-differentiated, mitotic count 2-20/2 mm2, Ki-67 3%-20% | NEC-G3: Poorly differentiated, mitotic count > 20/2 mm2, Ki-67 > 20% | |
| 2017/2019 | NET-G1: Well-differentiated, mitotic count < 2/2 mm2, Ki-67 ≤ 2% | NET-G2: Well-differentiated, mitotic count 2-20/2 mm2, Ki-67 3%-20% | NET-G3: Well-differentiated, mitotic count > 20/2 mm2, Ki-67 > 20% | NEC-G3: Poorly differentiated, mitotic count > 20/2 mm2, Ki-67 > 20% |
NET: Neuroendocrine tumor; NEC: Neuroendocrine carcinoma.